Skip to main content
. 2017 Dec 26;131(8):917–931. doi: 10.1182/blood-2017-09-807487

Figure 3.

Figure 3.

Cumulative incidence of TRM. (A) TRM for all patients was 11% (n = 29) at 1 year and 15% at 3 years. (B) TRM for patients with MRDs was 10% at 1 year and 22% at 3 years (n = 11) vs 11% at 1 year and 3 years for MUD/MMUD transplants (n = 18; P = .536). (C) TRM for patients with CGD was 10% at 1 year and at 3 years (n = 11) vs other PID 12% at 1 year and 3 years (n = 18; P = .73).